Medical-grade silicone elastomers market to reach $1.16 billion by 2030

The medical-grade silicone elastomers market is projected to grow from $0.84 billion in 2025 to $0.9 billion in 2026, according to a new forecast from The Business Research Company. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth as demand rises for implantable devices, sterilization-resistant materials and biocompatible medical components.

Why it matters: - Medical-grade silicone elastomers are a core material for devices that need flexibility, biocompatibility and resistance to heat, chemicals and sterilization. - Growth in implantable devices, wearable technologies and minimally invasive procedures is expanding demand for these materials. - The forecast signals continued investment in healthcare materials tied to long-term implants, advanced medical devices and high-purity formulations.

What happened: - The Business Research Company released a new forecast for the medical-grade silicone elastomers market on Oct. 15, 2026. - The market was valued at $0.84 billion in 2025 and is projected to reach $0.9 billion in 2026. - The report projects the market will reach $1.16 billion by 2030. - The forecast covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company made a free sample report and the full market report available online.

The details: - The market is expected to grow at a 6.8% CAGR from 2025 to 2026. - The forecast implies a 6.4% CAGR from 2026 to 2030. - Rising use of silicone-based medical devices is supporting demand. - Demand for flexible healthcare components is also contributing to market growth. - Long-term implantable solutions are a major use case for medical-grade silicone elastomers. - These materials are valued for compatibility with sterilization processes and chemical resistance. - The report highlights rising demand for innovative and biocompatible elastomer formulations. - The report also points to growing use in wearable and implantable medical devices. - Low leachable content and high-purity materials are becoming more important in procurement decisions. - Liquid silicone processing techniques are gaining traction. - Sterilization-resistant silicone variants, liquid silicone elastomers, platinum-cured silicones and low extractable materials are among the key trends identified. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report says its 2026 market editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards and market hotspot infographics.

Between the lines: - The forecast points to a market shaped less by broad consumer demand and more by the technical requirements of regulated medical applications. - The rising number of FDA regulatory actions for totally implanted spinal cord stimulation systems suggests stronger activity in one of the market’s highest-value end uses. - In 2024, the FDA reported about 94 premarket approval actions for totally implanted spinal cord stimulation systems, up from about 63 in 2023. - That increase supports the view that implantable-device demand is becoming a more important growth engine for medical-grade silicone elastomers. - North America’s lead likely reflects mature healthcare infrastructure and established regulatory pathways. - Faster growth in Asia-Pacific suggests expanding medical manufacturing and broader adoption of advanced devices in the region. - Saumya Sahay was listed as a contact for the report.

What's next: - Market growth will likely hinge on adoption of minimally invasive devices, wearable systems and long-term implants. - Suppliers are expected to keep emphasizing sterilization resistance, low extractables and biocompatibility. - The report points to continued momentum in liquid silicone processing and platinum-cured formulations.

The bottom line: - Medical-grade silicone elastomers are moving from a niche material category toward a broader strategic input for advanced healthcare devices, with implantables and high-spec medical applications driving the next phase of growth.